BiotechTube

riboflavin solution + placebo solution

Phase 3Terminated
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Keratoconus

Conditions

Keratoconus

Trial Timeline

Nov 1, 2013 → Apr 1, 2017

NCT ID
NCT01972854

About riboflavin solution + placebo solution

riboflavin solution + placebo solution is a phase 3 stage product being developed by Glaukos for Keratoconus. The current trial status is terminated. This product is registered under clinical trial identifier NCT01972854. Target conditions include Keratoconus.

What happened to similar drugs?

2 of 6 similar drugs in Keratoconus were approved

Approved (2) Terminated (0) Active (4)
🔄riboflavin solution + placebo solutionGlaukosPhase 3
🔄riboflavin ophthalmic solutionGlaukosPhase 3
✅Riboflavin 5'-PhosphateGlaukosApproved
🔄riboflavin solution + placebo solutionGlaukosPhase 3
🔄Test Article A + Test Article B + PlaceboGlaukosPhase 3
✅Dextenza + Prednisolone AcetateOcular TherapeutixApproved

Hype Score Breakdown

Clinical
17
Activity
0
Company
12
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT01972854Phase 3Terminated
NCT01344187Phase 3Completed
NCT01643226Phase 3Completed

Competing Products

7 competing products in Keratoconus

See all competitors
ProductCompanyStageHype Score
riboflavin solution + placebo solutionGlaukosPhase 3
37
riboflavin ophthalmic solutionGlaukosPhase 3
37
GLK-221 Ophthalmic Solution + Placebo Ophthalmic SolutionGlaukosPhase 2
39
Riboflavin 5'-PhosphateGlaukosApproved
40
riboflavin solution + placebo solutionGlaukosPhase 3
37
Test Article A + Test Article B + PlaceboGlaukosPhase 3
37
Dextenza + Prednisolone AcetateOcular TherapeutixApproved
37